UnityPoint’s corporate VC unit backed the series C round for Vida Diagnostics, a lung disease imaging technology provider.
Month: March 2020
VDN Cloud floats to Legend Capital for funding
Legend Capital took part in a $14.3m series A-plus round for the edge computing services provider that will fund marketing and R&D.
Analysis: Beike Zhaofang moves to $2.4bn round
Corporates Tencent and SoftBank invested in a $2.41bn round raised by real estate platform Beike Zhaofang at a reported $14bn valuation. The transaction is part of the broader real estate tech space which has seen a surge in valuations in recent years.
Corporate venturing deal net: 9-13 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Hell in a hand cart or usual correction?
From complacency to fear can happen to people in seemingly an instant.
Kymera kits out $102m series C round
The immunotherapy developer, which counts Pfizer, Sanofi, Merck & Co, Eli Lilly, Amgen and Vertex Pharmaceuticals as early investors, has picked up $102m.
Imara implements IPO
Pfizer and Lundbeck scored exits as blood-disease therapy developer Imara raised $75.2m, floating at the foot of its range.
Albert accesses $50m in series B round
Personalised finance management service Albert secured $50m in a CapitalG-led round that included fellow corporate venturing vehicle American Express Ventures.
Harbour BioMed harnesses $75m
The antibody-based drug developer has now raised $210m altogether, with both SK Holdings and Legend Capital backing its series B-plus round.
Neolix achieves Leading Ideal investment
The driverless delivery vehicle developer has added $28.8m to its coffers, the round being led by electric carmaker and existing backer Leading Ideal.
ByteDance goes to Mountain Top with series B funding
The TV and social media-focused talent agency received $25.7m from ByteDance and has formed a strategic partnership with the coprorate.
Cardumen carves out $60m fund
Repsol is among the limited partners that have committed to the venture firm’s $60m first fund, which is expected to make 10 more investments before 2022.
B.well gets $16m prescription
The healthcare access platform developer closed a series A round led by UnityPoint Health Ventures that included fellow corporate VC unit Well Ventures and ThedaCare.
Passage Bio amasses $248m for IPO close
The genetic therapy developer, which had raised $126m in funding from investors including Eli Lilly and Access Industries, added $32.4m to the offering.